YORCANVIS
Live / Allowed — First extension granted (statement of use) (as of 09 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99315415
- Mark type
- Word mark
- Filed
- 01 Aug 2025
- Published for opposition
- 13 Jan 2026
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immune diseases and disorders, including psoriasis, lupus, and multiple sclerosis; none of the foregoing for use in connection with pharmaceutical preparations for use in oncology
Owner
- Alumis Inc., South San Francisco, CA, US
- Alumis Inc., South San Francisco, CA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 99315415 — MERCK SHARP & DOHME LLC v. Alumis Inc., filed 03 Feb 2026 (Terminated)
Prosecution history
- 10 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Oct 2026 — SOU EXTENSION 1 GRANTED
- 09 Oct 2026 — SOU EXTENSION 1 FILED
- 09 Oct 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 24 Jun 2026 — POST PUBLICATION AMENDMENT - ENTERED
- 24 Jun 2026 — ASSIGNED TO PETITION STAFF
- 24 May 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 05 May 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 03 Feb 2026 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jan 2026 — PUBLISHED FOR OPPOSITION
- 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Dec 2025 — ASSIGNED TO EXAMINER